VITTORIO, SERENA
VITTORIO, SERENA
Dipartimento di Scienze Farmaceutiche
Approaching Pharmacological Space: Events and Components
2025 G. Vistoli, C. Talarico, S. Vittorio, F. Lunghini, A. Mazzolari, A. Beccari, A. Pedretti
Human carnosinases: A brief history, medicinal relevance, and in silico analyses
2024 K. Chmielewska, S. Vittorio, S. Gervasoni, K. Dzierzbicka, I. Inkielewicz-Stepniak, G. Vistoli
Unraveling the parahormetic mechanism underlying the health-protecting effects of grapeseed procyanidins
2024 G. Baron, A. Altomare, L. Della Vedova, F. Gado, O. Quagliano, S. Casati, N. Tosi, L. Bresciani, D. Del Rio, G. Roda, A. D'Amato, C. Lammi, A. Macorano, S. Vittorio, G. Vistoli, L. Fumagalli, M. Carini, A. Leone, M. Marino, C. Del Bo', G. Miotto, F. Ursini, P. Morazzoni, G. Aldini
Syntheses, reactivity, and biological applications of coumarins
2024 A. Citarella, S. Vittorio, C. Dank, L. Ielo
Unraveling the parahormetic mechanism underlying the health-protecting effects of grapeseed procyanidins
2024 G. Baron, A. Altomare, L. Della Vedova, F. Gado, O. Quagliano, S. Casati, N. Tosi, L. Bresciani, D. Del Rio, G. Roda, A. D'Amato, C. Lammi, A. Macorano, S. Vittorio, G. Vistoli, L. Fumagalli, M. Carini, A. Leone, M. Marino, C. Del Bo’, G. Miotto, F. Ursini, P. Morazzoni, G. Aldini
Screening of Mpro Protease (SARS-CoV-2) Covalent Inhibitors from an Anthocyanin-Rich Blueberry Extract Using an HRMS-Based Analytical Platform
2024 A. Altomare, G. Baron, G. Cambiaghi, G. Ferrario, B. Zoanni, L. Della Vedova, G.M. Fumagalli, S. D'Alessandro, S. Parapini, S. Vittorio, G. Vistoli, P. Riso, M. Carini, S. Delbue, G. Aldini
Discovery of a septin-4 covalent binder with antimetastatic activity in a mouse model of melanoma
2024 F. Blua, C. Monge, S. Gastaldi, N. Clemente, S. Pizzimenti, L. Lazzarato, R. Senetta, S. Vittorio, C.L. Gigliotti, E. Boggio, U. Dianzani, G. Vistoli, A.A. Altomare, G. Aldini, C. Dianzani, E. Marini, M. Bertinaria
New potent muscarinic receptor ligands bearing the 1,4‐dioxane nucleus: Investigation on the nature of the substituent in position 2
2024 G. Giorgioni, A. Bonifazi, R. Matucci, F. Matteucci, A. Piergentili, A. Piergentili, W. Quaglia, S. Gervasoni, G. Vistoli, S. Vittorio, F. Del Bello
Addressing docking pose selection with structure-based deep learning: Recent advances, challenges and opportunities
2024 S. Vittorio, F. Lunghini, P. Morerio, D. Gadioli, S. Orlandini, P. Silva, N. Jan Martinovic, A. Pedretti, D. Bonanni, A. Del Bue, G. Palermo, G. Vistoli, A.R. Beccari
Benign-by-Design SAHA Analogues for Human and Animal Vector-Borne Parasitic Diseases
2024 M. Rossi, B. Martinengo, E. Diamanti, A. Salerno, N. Rizzardi, R. Fato, C. Bergamini, A. Souza de Oliveira, T. de Araujo Marques Ferreira, C. Andrade Holanda, L.A.S. Romeiro, M.D.N.C. Soeiro, K. Nunes, L. Ferreira de Almeida Fiuza, M. Meuser Batista, C.A.M. Fraga, H. E. A. Alkhalaf, E.K. Elmahallawy, G.U. Ebiloma, H.P. De Koning, S. Vittorio, G. Vistoli, C. Blanquart, P. Bertrand, M.L. Bolognesi
Discovery of a New Class of 1-(4-Sulfamoylbenzoyl)piperidine-4-carboxamides as Human Carbonic Anhydrase Inhibitors
2024 D. Moi, S. Vittorio, A. Angeli, C.T. Supuran, V. Onnis
Investigation on Hydrazonobenzenesulfonamides as Human Carbonic Anhydrase I, II, IX and XII Inhibitors
2023 D. Moi, S. Vittorio, A. Angeli, G. Balboni, C.T. Supuran, V. Onnis
Heterocyclic Compounds as Synthetic Tyrosinase Inhibitors: Recent Advances
2023 S. Vittorio, C. Dank, L. Ielo
Ensemble of structure and ligand-based classification models for hERG liability profiling
2023 S. Vittorio, F. Lunghini, A. Pedretti, G. Vistoli, A.R. Beccari
The VEGA web service: multipurpose online tools for molecular modelling and docking analyses
2023 A. Pedretti, S. Vittorio, E. Sabato, G. Vistoli, A. Mazzolari
Computational Insights into the Sequence-Activity Relationships of the NGF(1-14) Peptide by Molecular Dynamics Simulations
2022 S. Vittorio, C. Manelfi, S. Gervasoni, A.R. Beccari, A. Pedretti, G. Vistoli, C. Talarico
An integrated metabolomic and proteomic approach for the identification of covalent inhibitors of the main protease (Mpro) of SARS-COV-2 from crude natural extracts
2022 G. Baron, S. Borella, L. Della Vedova, S. Vittorio, G. Vistoli, M. Carini, G. Aldini, A. Altomare